2025 has been the best year for biotechs being acquired by pharma companies since 2019, with nearly $240 billion worth of ...

Looking for top-rated stocks to buy now? Recent analyst updates highlight three companies that have earned Strong Buy ratings ...

Fortress and its majority-owned subsidiary, Cyprium Therapeutics, said the FDA has accepted an NDA resubmission for CUTX-101, or copper histidinate, a treatment for children who suffer from Menkes ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...